Incorporating New Therapies in IBS-C

1
Incorporating New Therapies in IBS-C
2
Patient Case
3
Is it Irritable Bowel Syndrome With Constipation?
4
What is IBS?
5
Pathophysiology of IBS
6
When Constipation Does Not Respond to First-line
Treatment
7
IBS Diagnostic Testing
8
Cornerstones of Treatment for the Patient With IBS
9
Are Behavioral Therapies Useful in IBS?
10
Antispasmodics, Antidepressants, Laxatives
11
New and Emerging Treatments
12
Long-term Efficacy of LubiprostoneMonthly
Responder Rates
13
Effects of Guanylate Cyclase-C Receptor
Activation
14
Linaclotide for IBS-C Adequate Relief of IBS
Symptoms for 13/26 Weeks
15
Prucalopride for Chronic ConstipationPost-hoc
Analysis of Phase III Data From Patients Who Had
Failed Previous Laxative Therapies
16
Elobixibat Mechanism of Action
17
Patient Case Conclusion
18
Abbreviations
19
Abbreviations (cont)
20
References
21
References (cont)
22
References (cont)
23
References (cont)